Darling Ingredients Boosts Buyback Authorization to $1 Billion

Corporate ActionEarnings
โดย Simply Wall St·US·Read original
Summary · why it matters

Darling Ingredients has increased its equity buyback authorization, lifting the remaining capacity to $500 million and bringing the total program size to $1.00 billion. The company reported $1,724.08 million in quarterly sales and $387.31 million in net income for Q2 2026, a sharp improvement from a year earlier. Operating margin improved by 9.5 percentage points over the past year despite a 2.5% annual revenue decline over three years. Management's focus on efficiency and capital return comes amid top-line pressure and unresolved policy risks around RINs, LCFS credits, and small refinery exemptions.

Impact on stocks 1

Synthetic Biology (non-pharma) · 1 stocks
Darling Ingredients Inc
DAR
▲ PositiveCapitalrelevance

Company boosts buyback authorization to $1 billion, signaling capital return commitment.